GO
Loading...

Cramer: Sell the HMOs

If the recent performance of HMO stocks is any indication, Cramer said during Wednesday’s Stop Trading!, then some form of a public-option insurance plan will be available to consumers.

Unitedhealth Group , WellPoint and Humana have seen significant declines over the past couple of weeks, which Cramer attributed to a compromise being struck on this contentious piece of President Obama’s intended health-care reforms.

The public option was voted down in the Senate Finance Committee on Tuesday, but he said he expected a lesser version to pass. That could be bad news for the HMOs.

“This group must be sold,” Cramer said, reiterating his Tuesday call.

Elsewhere in the market, Exelon is “the real winner” when it comes to the Senate’s cap-and-trade bill, Cramer said. The company’s nuclear-power exposure offers the biggest advantage under the proposed legislation.

“The stock’s way off,” Cramer said, giving investors a great entry point.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book